Home Trending News Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics Partnering...

Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics Partnering Insights and Analysis 2018

46
0
SHARE

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, the report provides details of M&A agreements from 2010 to 2017.

The report provides a detailed understanding and analysis of how and why companies enter M&A deals. The majority of deals are acquisitions whereby the acquirer acquires the target company in a cash and/or equity transaction. Merger and acquisition is a constant activity within the biopharma sector. In the past, biopharma companies have sought to merge or acquire competitor companies in order to achieve critical mass both in R&D and sales and marketing, thus ensuring continued growth and dominance in a highly competitive and global marketplace.

Avail a sample 200 Pages copy before purchase: https://www.industrydataanalytics.com/request-sample-page.php?gturl=19204?source=insidertradings&Mode=19

In 1987, the largest ten companies were responsible for approximately twelve percent of global pharmaceutical sales. By 2002, this figure had become nearly fifty percent. This concentration was principally due to big pharma mega mergers

Report scope:

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 is intended to provide the reader with an in-depth understanding of the M&A trends and structure of deals entered into by leading biopharma companies worldwide.

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 includes: 
Trends in M&A dealmaking in the biopharma industry since 2010
Analysis of M&A deal structure
Case studies of real-life M&A deals
Access to over 2,200 M&A deal records
The leading M&A deals by value since 2010
Most active M&A dealmakers since 2010

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 provides the reader with the following key benefits:

In-depth understanding of M&A deal trends since 2010
Analysis of the structure of M&A agreements with numerous real life case studies
Comprehensive access to over 2,200 actual M&A deals entered into by the world’s biopharma companies
Detailed access to actual M&A deals entered into by the leading fifty bigpharma companies
Insight into the terms included in a M&A agreement, together with real world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Avail complete report of this research with TOC and List of Figures at: https://www.industrydataanalytics.com/global-merger-and-acquisition-terms-and-agreements-in-pharma-biotech-and-diagnostics-2010-2017-19204-p.php?source=insidertradings&Mode=19

The initial chapters of this report provide an orientation of M&A dealmaking and business activities.

Chapter 1 provides an introduction to the report, whilst

Chapter 2 provides an analysis of the trends in M&A as well as a discussion on the merits of the type of deal.
Chapter 3 provides an overview of the structure of M&A deals. The chapter includes numerous case studies to enable understanding of M&A deals.
Chapter 4 provides a review of the leading M&A deals since 2010. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 5 provides a review of the top 50 most active biopharma companies in M&A. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.
Chapter 6 provides a comprehensive review of M&A financials for deals announced since 2010, including headline value, providing both benchmark data and access to individual deal financials.
Chapter 7 provides a comprehensive and detailed review of M&A deals signed and announced since 2010 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

About us: Industrydataanalytics provides syndicated Market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. Industrydataanalytics has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. +1 (704) 266-3234 | mail to: sales@industrydataanalytics.com